⌘K
Loading ticker…
As of 2026-08-24, Adaptive Biotechnologies Corporation Common Stock (ADPT) has a 3-month relative strength percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 74. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.3%, relative volume 0.68×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ADPT is in a stage 2 uptrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 15.4% / 48.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ADPT appears in 1 ETF as of Jun 2026: PSC at 0.18% weight, $4M notional.
Held by 65 ETFs · $305M across latest filings · largest weight 3.12% (HELX).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.18% | $4M | +0.04 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ADPT Jan avg: 9.86% median: 17.63% win: 75% σ: 24.13% n: 4 2022-04-12 → 2026-07-31 | ADPT Feb avg: -0.65% median: -0.59% win: 50% σ: 11.91% n: 4 2022-04-12 → 2026-07-31 | ADPT Mar avg: -10.51% median: -11.70% win: 25% σ: 10.46% n: 4 2022-04-12 → 2026-07-31 | ADPT Apr avg: -13.68% median: -18.38% win: 20% σ: 13.84% n: 5 2022-04-12 → 2026-07-31 | ADPT May avg: 12.15% median: 7.45% win: 60% σ: 17.44% n: 5 2022-04-12 → 2026-07-31 | ADPT Jun avg: 13.75% median: 4.93% win: 80% σ: 18.26% n: 5 2022-04-12 → 2026-07-31 | ADPT Jul avg: 11.56% median: 13.23% win: 80% σ: 15.85% n: 5 2022-04-12 → 2026-07-31 | ADPT Aug avg: 2.40% median: 0.34% win: 50% σ: 20.09% n: 4 2022-04-12 → 2026-07-31 (current) | ADPT Sep avg: -4.31% median: -5.28% win: 50% σ: 18.03% n: 4 2022-04-12 → 2026-07-31 | ADPT Oct avg: 0.33% median: 1.90% win: 50% σ: 15.45% n: 4 2022-04-12 → 2026-07-31 | ADPT Nov avg: 11.87% median: 13.05% win: 75% σ: 9.93% n: 4 2022-04-12 → 2026-07-31 | ADPT Dec avg: -4.40% median: -6.03% win: 50% σ: 13.36% n: 4 2022-04-12 → 2026-07-31 |